Prof Henrik Zetterberg, Sweden
April 22, 2022
What is the potential of biomarkers for Alzheimer's disease in primary care? Hear Prof. Henrik Zetterberg from Sweden share his thoughts..
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.